Rainbow trout, Oncorhynchus mykiss, as a model for aromatase inhibition

Journal of Steroid Biochemistry and Molecular Biology

Volumn 70, Issue 1-3, 1999, Pages 89-95

  Shilling, A D ^a   Carlson, D B ^a   Williams, D E ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; FORMESTANE; LETROZOLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; IN VITRO STUDY; MICROSOME; RAINBOW TROUT;

ANIMALS; ANTIFUNGAL AGENTS; AROMATASE INHIBITORS; CLOTRIMAZOLE; DEHYDROEPIANDROSTERONE; ENZYME INHIBITORS; FEMALE; HUMANS; KINETICS; MICROSOMES; MODELS, BIOLOGICAL; NITRILES; ONCORHYNCHUS MYKISS; OVARY; RATS; TRIAZOLES; VITELLOGENESIS;

EID: 0032858596     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00090-4     Document Type: Article

References (46)

1. Blamey R.W. The role of selective non-steroidal aromatase inhibitors in future treatment strategies. Oncology. 54:1997;27-31.
2. Miller W.R. Aromatase inhibitors and breast cancer. Cancer Treat. Rev. 23:1997;171-187.
3. Brodie A.M.H. Aromatase, its inhibitors and their use in breast cancer treatment. J. Steroid Biochem. Molec. Biol. 60:1993;501-515.
4. Newton C.J., Mehta A., Dowsett M. The effect of the aromatase inhibitor, rogletimide (pyridoglutethimide), on guinea pig adrenal cell steroidogenesis and placental microsomal aromatase activity: comparison with aminoglutethimide and CGS 16949A. J. Steroid Biochem. Molec. Biol. 39:1991;723-727.
5. Cash R., Brough A.J., Cohen M.N.P., Satoh P. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. J. Clin Endocr. Metab. 27:1967;1239-1248.
6. Halpert J.R., Guengerich F.P., Bend J.R., Correia M.A. Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 125:1994;163-175.
7. Plourde P.V., Dyroff M., Dowsett M., Demers L., Yates R., Webster A. Arimidex: a new oral, once-a-day aromatase inhibitor. J. Steroid Biochem. Molec. Biol. 53:1995;175-179.
8. Yano S., Ikegami Y., Nakao K. Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneim. Forsch/Drug Res. 46:1996;192-195.
9. Dowsett M., Lee K., Macaulay V.M., Detre S., Rowlands M., Grimshaw R. The control and biological importance of intratumoural aromatase in breast cancer. J. Steroid Biochem. Molec. Biol. 56:1996;145-150.
10. Ingle J.N., Johnson P.A., Suman V.J., Gerstner J.B., Mailliard J.A., Camoriano J.K., Gesme D.H. Jr., Loprinzi C.L., Hatfield A.K., Hartmann L.C. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer. 80:1997;218-224.
11. Kelloff G.J., Lubet R.A., Lieberman R., Eisenhower K., Stelle V.E., Crowell J.A., Hawk E.T., Boone C.W., Sigman C.C. Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiology, Biomarkers and Prevention. 7:1998;65-78.
12. Safe S.H. Environmental and dietary estrogens and human health: is there a problem? Environ. Health Perspect. 103:1995;346-351.
13. Gillesby B.E., Zacharewski T.R. Exoestrogens: mechanisms of action and strategies for identification and assessment. Environ. Toxicol. Chem. 17:1998;3-14.
14. Wibbels T., Crews D. Putative aromatase inhibitor induces male sex determination in a female unisexual lizard and in a turtle with temperature-dependent sex determination. J. Endocr. 141:1994;295-299.
15. Crews D., Bergeron J.M. Role of reductase and aromatase in sex determination in the red-eared slider (Trachemys scripta), a turtle with temperature-dependent sex determination. J. Endocr. 143:1994;279-289.
16. Wibbels T., Crews D. Specificity of steroid hormone-induced sex determination in a turtle. J. Endocr. 133:1992;121-129.
17. Austin H.B. The effects of norethindrone on the mullerian ducts of the northern alligator. Gen. Comp. Endocr. 84:1991;300-307.
18. Lance V.A., Bogart M.H. Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor. Gen. Comp. Endocr. 86:1992;59-71.
19. Richard-Mercier N., Dorizzi M., Desvagies G., Girondot M., Pieau C. Endocrine sex reversal of gonads by the aromatase inhibitor letrozole (CGS 20267) in Emys orbicularis, a turtle with temperature-dependent sex determination. Gen. Comp. Endocr. 100:1995;314-325.
20. Pelissero C., Lenczowski M.J.P., Chinzi D., Davail-Cuisset B., Sumpter J.P., Fostier A. Effects of flavonoids on aromatase activity, an in vitro study. J. Steroid Biochem. Molec. Biol. 57:1996;215-223.
21. Monad G. Inhibition of ovarian microsomal aromatase follicular oestradiol secretion by imidazole fungicides in rainbow trout. Marine Environ. Res. 35:1993;153-157.
22. Bailey G.S., Williams D.E., Hendricks J.D. Fish models for environmental carcinogenesis: the rainbow trout. Environ. Health Perspect. 104:1996;5-21.
23. Bailey G.S., Hendricks J.D., Dashwood R. Anticarcinogenesis in fish. Mutat. Res. 267:1992;243-250.
24. Nunez O., Hendricks J.D., Arbogast D.N., Fong A.T., Lee B.C., Bailey G.S. Promotion of aflatoxin B1 hepatocarcinogenesis in rainbow trout by 17β-estradiol. Aquat. Toxicol. 15:1989;289-302.
25. Orner G.A., Hendricks J.D., Arbogast D., Williams D.E. Modulation of aflatoxin-B1 hepatocarcinogenesis in trout by dehydroepiandrosterone: initiation/post-initiation and latency effects. Carcinogenesis. 19:1998;161-168.
26. Orner G.A., Hendricks J.D., Arbogast D., Williams D.E. Modulation of N-methyl-N′-nitro-nitrosoguanidine multiorgan carcinogenesis by dehydroepiandrosterone in rainbow trout. Toxicol. Appl. Pharmacol. 141:1996;548-554.
27. Orner G.A., Mathews C., Hendricks J.D., Carpenter H.M., Bailey G.S., Williams D.E. Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout. Carcinogenesis. 16:1995;2893-2898.
28. Guengerich F.P. Analysis and characterization of enzymes. Wallace Hayes A. Principles and Methods of Toxicology. 2nd ed. 1989;777-813 Raven Press, New York.
29. Thompson E., Siiteri P.K. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 249:1974;5364-5372.
30. Lowry O.H., Rosebrough N.J., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. Wozniak A., Holman S.D., Hutchinson J.B. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain. J. Steroid Biochem. Mol. Biol. 43:1992;281-287.
32. Lee B.C., Hendricks J.D., Bailey G.S. Toxicity of mycotoxins in the feed of fish. Smith J.E. Mycotoxins and animal feedstuff: natural occurrence, toxicity and control. 1991;607-626 CRC Press, Boca Raton.
33. Sumpter J.P., Jobling S. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect. 103:1995;173-178.
34. Palmer B.D., Palmer S.K. Vitellogenin induction by xenobiotic estrogens in the red eared African clawed frog. Environ. Health Perspect. 103:1995;19-25.
35. Donohoe R.M., Curtis L.R. Estrogenic activity of chlordecone, o,p′-DDT and o,p′-DDE in juvenile rainbow trout: induction of vitellogenesis and interaction with hepatic estrogen binding sites. Aquat. Toxicol. 36:1996;31-52.
36. Lang M., Batzl C., Furet P., Bowman R., Hausler A., Bhatnagar A.S. Structure-activity relationships and binding model of novel aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 44:1993;421-428.
37. Choate J.V.A., Resko J.A. Paradoxical effect of an aromatase inhibitor, CGS 20267, on aromatase activity in guinea pig brain. J. Steroid Biochem. Mol. Biol. 58:1996;411-415.
38. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetra-chlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. 88:1991;9543-9547.
39. Stresser D.M., Bjelddanes L.F., Bailey G.S., Williams D.E. The anticarcinogen 3,3′-diindolylmethane is an inhibitor of cytochrome P450. J. Biochem. Toxicol. 10:1995;191-201.
40. Kellis J.T. Jr., Vickery L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 225:1984;1032-1034.
41. Wang C., Makela T., Hase T., Adlercreutz H., Kurzer M.S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Mol. Biol. 50:1994;205-212.
42. Orner G.A., Donohoe R.M., Hendricks J.D., Curtis L.R., Williams D.E. Comparison of the enhancing effects of dehydroepiandrosterone with structural analog 16α-fluoro-5-androsten-17-one on aflatoxin B1 hepatocarcinogenesis in rainbow trout. Fund. Appl. Toxicol. 34:1996;132-140.
43. Wang D.Y., Hayward J.L., Bulbrook R.D., Kumaoka S., Takatani O., Abe O., Utsunamiya J. Plasma dehydroepiandrosterone and androsterone sulfates, androstenedione and urinary androgen metabolites in normal British and Japanese women. Eur. J. Cancer. 12:1976;951-958.
44. Gregus Z., Watkins J.B., Thompson T.N., Harvey M.J., Rozman K., Klaassen C.D. Hepatic phase I and phase II biotransformations in quail and trout: comparison to other species commonly used in toxicity testing. Toxicol. Appl. Pharmacol. 67:1983;430-441.
45. Brodie A.M.H., Wing L.Y., Goss P., Dowsett M., Coombes R.C. Aromatase inhibitors and the treatment of breast cancer. J. Steroid Biochem. 24:1986;91-97.
46. De Coster R., Wouters W., Bruynseels J. P450-dependent enzymes as targets for prostate cancer therapy. J. Steroid Biochem. Mol. Biol. 56:1996;133-143.